Suppr超能文献

美国太平洋附属岛屿的紧凑国家的血液透析:历史和医疗保健影响。

Hemodialysis in the Compact Nations of the US Affiliated Pacific: History and Health Care Implications.

机构信息

Department of Family Medicine and Community Health, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI (MSM, NAP).

St. Francis Medical Center, Renal Institute of the Pacific, Honolulu, HI (AWS).

出版信息

Hawaii J Health Soc Welf. 2020 Jun 1;79(6 Suppl 2):113-119.

Abstract

The epidemic of non-communicable disease in the Compact nations of the US Affiliated Pacific Islands and the associated renal complications drive the demand for hemodialysis. Limited healthcare budgets and a lack of trained human health resources in these areas make hemodialysis a challenging undertaking that may require significant sacrifices in competing health care priorities. Two nephrologists who developed hemodialysis in the US Affiliated Pacific Islands provide its history. Cost estimates of hemodialysis for the Compact nations are collected from a 2014 hemodialysis feasibility report. The experiences and outcomes of current hemodialysis centers in the United States and other island nations provide a framework by which to assess the potential benefit and impact of hemodialysis in the Compact nations. A consideration of how and why different stakeholders value hemodialysis will be crucial because they will drive the public's response to the institutionalization of any new intervention or the cessation of any existing intervention like hemodialysis. Updated cost estimates for dialysis clinics and data on renal disease rates in the Compact nations will be necessary to make informed decisions about hemodialysis in the current health systems. In the meantime, it is essential to enhance current medical interventions and public health strategies to prevent kidney disease and decrease the risks for kidney failure. Such preventive interventions must be culturally appropriate, effective, cost-efficient, and sustainable in the unique context of the Pacific.

摘要

美属太平洋岛屿联邦国家的非传染性疾病流行以及由此引发的肾脏并发症推动了对血液透析的需求。这些地区的医疗保健预算有限,且缺乏训练有素的人力资源,使得血液透析成为一项具有挑战性的任务,可能需要在竞争激烈的医疗保健重点上做出重大牺牲。两位在美属太平洋岛屿联邦国家开展血液透析的肾病学家提供了其历史背景。从 2014 年血液透析可行性报告中收集了针对小型岛屿国家联盟的血液透析成本估算数据。美国和其他岛国当前血液透析中心的经验和结果为评估血液透析在小型岛屿国家联盟中的潜在益处和影响提供了一个框架。考虑不同利益相关者如何以及为何重视血液透析将至关重要,因为他们将推动公众对任何新干预措施的制度化或对现有干预措施(如血液透析)的停止做出反应。需要更新透析诊所的成本估算和小型岛屿国家联盟肾脏疾病发病率数据,以便在当前卫生系统中就血液透析做出明智决策。与此同时,必须加强现有的医疗干预措施和公共卫生战略,以预防肾脏疾病并降低肾衰竭的风险。这种预防干预措施必须在太平洋地区独特的文化背景下具有文化适宜性、有效性、成本效益和可持续性。

相似文献

2
Dialysis Care and Dialysis Funding in Asia.
Am J Kidney Dis. 2020 May;75(5):772-781. doi: 10.1053/j.ajkd.2019.08.005. Epub 2019 Nov 5.
3
Hemodialysis.
N Engl J Med. 2010 Nov 4;363(19):1833-45. doi: 10.1056/NEJMra0902710.
4
My addiction: the artificial kidney, the rise and fall of dialysis.
Artif Organs. 2012 Jul;36(7):575-80. doi: 10.1111/j.1525-1594.2012.01501.x.
6
God panels and the history of hemodialysis in America: a cautionary tale.
Virtual Mentor. 2012 Nov 1;14(11):890-6. doi: 10.1001/virtualmentor.2012.14.11.mhst1-1211.
7
A bumpy road to maintenance hemodialysis.
Artif Organs. 2012 Oct;36(10):849-51. doi: 10.1111/j.1525-1594.2012.01550.x.
9
The early history of dialysis for chronic renal failure in the United States: a view from Seattle.
Am J Kidney Dis. 2007 Mar;49(3):482-96. doi: 10.1053/j.ajkd.2007.01.017.
10
[Renal replacement therapy by hemodialysis: an overview].
Nephrol Ther. 2009 Jul;5(4):306-12. doi: 10.1016/j.nephro.2009.03.001. Epub 2009 May 28.

引用本文的文献

2
Health disparities and climate change in the Marshall Islands.
Ann Med. 2024 Dec;56(1):2411601. doi: 10.1080/07853890.2024.2411601. Epub 2024 Oct 11.
3
Haemodialysis in Samoa: A model for other Pacific nations.
Lancet Reg Health West Pac. 2020 Dec 8;6:100071. doi: 10.1016/j.lanwpc.2020.100071. eCollection 2021 Jan.

本文引用的文献

1
Peritoneal Dialysis Access Associated Infections.
Adv Chronic Kidney Dis. 2019 Jan;26(1):23-29. doi: 10.1053/j.ackd.2018.09.002.
2
Tuberculosis in dialysis: Clinical spectrum and outcome from an endemic region.
Hemodial Int. 2019 Jan;23(1):88-92. doi: 10.1111/hdi.12693. Epub 2018 Oct 5.
4
Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release Assay.
Medicine (Baltimore). 2016 May;95(22):e3813. doi: 10.1097/MD.0000000000003813.
5
Diabetes and end-stage renal disease; a review article on new concepts.
J Renal Inj Prev. 2015 Jun 1;4(2):28-33. doi: 10.12861/jrip.2015.07. eCollection 2015.
6
Medicare's End Stage Renal Disease Program.
Health Care Financ Rev. 2000 Fall;22(1):55-60.
7
Risk factors for chronic kidney disease: an update.
Kidney Int Suppl (2011). 2013 Dec;3(4):368-371. doi: 10.1038/kisup.2013.79.
8
Updates on the management of diabetes in dialysis patients.
Semin Dial. 2014 Mar;27(2):135-45. doi: 10.1111/sdi.12198.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验